These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 31105702)

  • 21. Regulatory T-cell suppression of CD8+ T-cell-mediated graft-versus-host reaction requires their presence during priming.
    Wang XN; Haniffa MA; Holtick U; Collin MP; Jackson G; Hilkens CM; Holler E; Edinger M; Hoffmann P; Dickinson AM
    Transplantation; 2009 Jul; 88(2):188-97. PubMed ID: 19623013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retinoic acid-responsive CD8 effector T cells are selectively increased in IL-23-rich tissue in gastrointestinal GVHD.
    Ball JA; Clear A; Aries J; Charrot S; Besley C; Mee M; Stagg A; Lindsay JO; Cavenagh J; Calaminci M; Gribben JG; Davies J
    Blood; 2021 Feb; 137(5):702-717. PubMed ID: 32905596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutting edge: in vivo trogocytosis as a mechanism of double negative regulatory T cell-mediated antigen-specific suppression.
    Ford McIntyre MS; Young KJ; Gao J; Joe B; Zhang L
    J Immunol; 2008 Aug; 181(4):2271-5. PubMed ID: 18684915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FcRγ controls the fas-dependent regulatory function of lymphoproliferative double negative T cells.
    Juvet SC; Thomson CW; Kim EY; Han M; Zhang L
    PLoS One; 2013; 8(6):e65253. PubMed ID: 23762329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD4-CD8-C.B-17 SCID thymocytes enter the CD4+CD8+ stage in the presence of neonatally grafted T cells.
    Schneider MK; Grönvik KO
    Scand J Immunol; 1998 May; 47(5):466-74. PubMed ID: 9627131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opposing effects of ICOS on graft-versus-host disease mediated by CD4 and CD8 T cells.
    Yu XZ; Liang Y; Nurieva RI; Guo F; Anasetti C; Dong C
    J Immunol; 2006 Jun; 176(12):7394-401. PubMed ID: 16751384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of defective CD4-CD8- T cells in murine tumors generated independent of antigen specificity.
    Prins RM; Incardona F; Lau R; Lee P; Claus S; Zhang W; Black KL; Wheeler CJ
    J Immunol; 2004 Feb; 172(3):1602-11. PubMed ID: 14734741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naive and Stem Cell Memory T Cell Subset Recovery Reveals Opposing Reconstitution Patterns in CD4 and CD8 T Cells in Chronic Graft vs. Host Disease.
    Soares MV; Azevedo RI; Ferreira IA; Bucar S; Ribeiro AC; Vieira A; Pereira PNG; Ribeiro RM; Ligeiro D; Alho AC; Soares AS; Camacho N; Martins C; Lourenço F; Moreno R; Ritz J; Lacerda JF
    Front Immunol; 2019; 10():334. PubMed ID: 30894856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-10 Gene-Modified Dendritic Cell-Induced Type 1 Regulatory T Cells Induce Transplant-Tolerance and Impede Graft Versus Host Disease After Allogeneic Stem Cell Transplantation.
    Wan J; Huang F; Hao S; Hu W; Liu C; Zhang W; Deng X; Chen L; Ma L; Tao R
    Cell Physiol Biochem; 2017; 43(1):353-366. PubMed ID: 28869950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined OX40L and mTOR blockade controls effector T cell activation while preserving T
    Tkachev V; Furlan SN; Watkins B; Hunt DJ; Zheng HB; Panoskaltsis-Mortari A; Betz K; Brown M; Schell JB; Zeleski K; Yu A; Kirby I; Cooley S; Miller JS; Blazar BR; Casson D; Bland-Ward P; Kean LS
    Sci Transl Med; 2017 Sep; 9(408):. PubMed ID: 28931653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human monocyte-derived suppressor cells control graft-versus-host disease by inducing regulatory forkhead box protein 3-positive CD8+ T lymphocytes.
    Janikashvili N; Trad M; Gautheron A; Samson M; Lamarthée B; Bonnefoy F; Lemaire-Ewing S; Ciudad M; Rekhviashvili K; Seaphanh F; Gaugler B; Perruche S; Bateman A; Martin L; Audia S; Saas P; Larmonier N; Bonnotte B
    J Allergy Clin Immunol; 2015 Jun; 135(6):1614-24.e4. PubMed ID: 25630940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-2 Enhances the Regulatory Functions of CD4(+)T Cell-Derived CD4(-)CD8(-) Double Negative T Cells.
    Cong M; Liu T; Tian D; Guo H; Wang P; Liu K; Lin J; Tian Y; Shi W; You H; Jia J; Zhang D
    J Interferon Cytokine Res; 2016 Aug; 36(8):499-505. PubMed ID: 27135902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting of PI3K/AKT/mTOR pathway to inhibit T cell activation and prevent graft-versus-host disease development.
    Herrero-Sánchez MC; Rodríguez-Serrano C; Almeida J; San Segundo L; Inogés S; Santos-Briz Á; García-Briñón J; Corchete LA; San Miguel JF; Del Cañizo C; Blanco B
    J Hematol Oncol; 2016 Oct; 9(1):113. PubMed ID: 27765055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive Analysis of the Activation and Proliferation Kinetics and Effector Functions of Human Lymphocytes, and Antigen Presentation Capacity of Antigen-Presenting Cells in Xenogeneic Graft-Versus-Host Disease.
    Kawasaki Y; Sato K; Hayakawa H; Takayama N; Nakano H; Ito R; Mashima K; Oh I; Minakata D; Yamasaki R; Morita K; Ashizawa M; Yamamoto C; Hatano K; Fujiwara SI; Ohmine K; Muroi K; Kanda Y
    Biol Blood Marrow Transplant; 2018 Aug; 24(8):1563-1574. PubMed ID: 29678638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autocrine IFNγ controls the regulatory function of lymphoproliferative double negative T cells.
    Juvet SC; Han M; Vanama R; Joe B; Kim EY; Zhao FL; Jeon C; Adeyi O; Zhang L
    PLoS One; 2012; 7(10):e47732. PubMed ID: 23077665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mammalian target of rapamycin inhibitors permit regulatory T cell reconstitution and inhibit experimental chronic graft-versus-host disease.
    Sugiyama H; Maeda Y; Nishimori H; Yamasuji Y; Matsuoka K; Fujii N; Kondo E; Shinagawa K; Tanaka T; Takeuchi K; Teshima T; Tanimoto M
    Biol Blood Marrow Transplant; 2014 Feb; 20(2):183-91. PubMed ID: 24333142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of CD3+CD4-CD8- (double negative) T cells reconstitution in patients following hematopoietic stem-cell transplantation.
    Ye H; Chang Y; Zhao X; Huang X
    Transpl Immunol; 2011 Dec; 25(4):180-6. PubMed ID: 21911061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epicutaneous immunization induces alphabeta T-cell receptor CD4 CD8 double-positive non-specific suppressor T cells that inhibit contact sensitivity via transforming growth factor-beta.
    Szczepanik M; Bryniarski K; Tutaj M; Ptak M; Skrzeczynska J; Askenase PW; Ptak W
    Immunology; 2005 May; 115(1):42-54. PubMed ID: 15819696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spi6 protects alloreactive CD4(+) but not CD8 (+) memory T cell from granzyme B attack by double-negative T regulatory cell.
    Su Y; Jevnikar AM; Huang X; Lian D; Zhang Z-
    Am J Transplant; 2014 Mar; 14(3):580-93. PubMed ID: 24730048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.